Marcia Wallace, our Supplier Diversity Program Manager, recently received the Advocate of the Year Award from the Women's Business Enterprise Center East (WBEC East). This honor is awarded to an employee, corporate or government strategic partner who has done the most to promote business opportunities for women-owned businesses in Pennsylvania, New Jersey and Delaware. Marcia was also included on DiversityPlus Magazine's 2024 list of Top 25 Diversity Change Leaders, which recognizes leaders who have made significant contributions to advancing diversity, equity and inclusion (DEI) within their organizations and communities. Congratulations Marcia!
Children's Hospital of Philadelphia
Hospitals and Health Care
Philadelphia, PA 127,894 followers
About us
Since its start in 1855 as the nation's first hospital devoted exclusively to caring for children, The Children's Hospital of Philadelphia has been the birthplace for many dramatic firsts in pediatric medicine. The Hospital has fostered medical discoveries and innovations that have improved pediatric healthcare and saved countless children’s lives. Today, The Children's Hospital of Philadelphia is one of the leading pediatric hospitals and research facilities in the world. Our 150 years of innovation and service to our patients, their families and our community reflect an ongoing commitment to exceptional patient care, training new generations of pediatric healthcare providers and pioneering significant research initiatives.
- Website
-
http://www.chop.edu
External link for Children's Hospital of Philadelphia
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Philadelphia, PA
- Type
- Nonprofit
- Founded
- 1855
- Specialties
- pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, hyperinsulinism, pediatric airway disorders, and transplants
Locations
-
Primary
34th St. and Civic Center Blvd.
Philadelphia, PA 19104, US
-
3401 Civic Center Blvd
Philadelphia, PA 19104, US
Employees at Children's Hospital of Philadelphia
Updates
-
We're excited to share that our Senior Vice President and Chief Digital and Information Officer, Shakeeb Akhter, has been appointed to CHIME's (College of Healthcare Information Management Executives) Board of Trustees. Effective January 2025, Shakeeb, along with other leaders comprised of prominent digital health and business experts, will play a pivotal role in guiding CHIME through continued innovation and transformation in the healthcare industry. Learn more about CHIME and Shakeeb's appointment: http://ms.spr.ly/6048mLlVk.
-
Members of our Division of Hematology, including Dr. Alexis Thompson, Chief of the Division, and Dr. Janet Kwiatkowski, Director of our Thalassemia Center, delivered presentations at this year's Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) held in Europe. The year's presentations centered around our expertise in gene therapy for sickle cell disease and thalassemia. Additionally, Dr. Kwiatkowski, who was a member on the ASCAT's Scientific Program Committee, discussed our Sickle Cell and Red Cell Disorders Curative Therapy Center (CuRED). CHOP's Drs. Abraham Haimed and Sarah Dain also shared research findings at ASCAT.
-
Earlier this week, researchers from our Center for Data Driven Discovery in Biomedicine received a grant for up to $10 million from the Advanced Research Projects Agency for Health (APRA-H) to validate and implement a new model for sharing and integrating data on complex diseases at a national level. This new model is designed to empower research on cancer and other rare diseases in real time.
-
We're thrilled to share that our leaders Calvin U. Allen, Sophia G. Holder, Donald Moore and Monica Taylor Lotty recently received The Philadelphia Tribune's Most Influential African Americans Award, which recognizes the impact they are making on Philadelphia. Please join us in congratulating them on this important honor!
-
We're thrilled to share that Fabian Stone, our Vice President of Revenue Cycle Operations, has been included on Becker's Healthcare's 2024 list of "Health IT & Revenue Cycle Up-and-Comers." Please join us in congratulating Fabian! Read the complete list: http://ms.spr.ly/6048mIJ0q.
-
A new CHOP study led by Dr. Michael LaRivere, an attending physician with the Pediatric Proton Therapy Center at CHOP, shows promising results for pediatric Hodgkin Lymphoma patients who underwent proton therapy to treat their disease in rare regions located below the diaphragm, such as the abdomen and pelvis. The study highlights the advantages of proton therapy over conventional photon radiotherapy, demonstrating fewer side effects and better protection for critical organs. The findings were recently published in the journal Pediatric Blood and Cancer. Learn more in the link below.
Researchers at Children's Hospital of Philadelphia Highlight Benefits of Proton Therapy for Pediatric Hodgkin Lymphoma Patients
chop.edu
-
We're thrilled to once again be named one of the Best Children’s Hospitals in the nation by U.S. News & World Report! From clinical expertise to life-changing research, we offer best-in-nation pediatric care for everything from the routine to the rare. Click here to learn more: http://ms.spr.ly/6045mIJmf.
-
We are honored to announce that we've received a Leading Disability Employer Seal for 2024 from the National Organization on Disability. This esteemed award recognizes exceptional disability inclusion practices and policies and is shared during National Disability Employment Awareness Month, which is celebrated each October. Learn more: http://ms.spr.ly/6048mIJ4k.
-
Join us in congratulating Dr. Evan Weber, one of our cell and gene therapy researchers, for being selected by the The National Institutes of Health as a 2024 grant recipient in the High-Risk, High-Reward Research program. These grants are designed to support highly innovative scientists who propose visionary and broadly impactful behavioral and biomedical research projects. Dr. Weber's research focuses on improving CAR-T design to modify T cell fitness so that the cells can provide more sustained immune response and longer lasting benefits to patients. Learn more in the link below.
http://ms.spr.ly/6040mIJCj
chop.edu